{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:38:13Z","timestamp":1793036293509,"version":"4.5.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"DOI":"10.1186\/s40364-026-00931-1","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:05:39Z","timestamp":1779447939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-cell transcriptomic mapping of immune heterogeneity across angioimmunoblastic T-cell lymphoma subtypes"],"prefix":"10.1186","volume":"14","author":[{"given":"Huimin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lugui","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiapei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"3","key":"931_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1182\/blood.2020010387","volume":"138","author":"RH Advani","year":"2021","unstructured":"Advani RH, Skrypets T, Civallero M, Spinner MA, Manni M, Kim WS, et al. Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project. Blood. 2021;138(3):213\u201320. https:\/\/doi.org\/10.1182\/blood.2020010387.","journal-title":"Blood"},{"issue":"1","key":"931_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3322\/caac.21589","volume":"70","author":"E Marchi","year":"2020","unstructured":"Marchi E, O\u2019Connor OA. The rapidly changing landscape in mature T-cell lymphoma (MTCL) biology and management. CA Cancer J Clinicians. 2020;70(1):47\u201370. https:\/\/doi.org\/10.3322\/caac.21589.","journal-title":"CA Cancer J Clinicians"},{"issue":"9","key":"931_CR3","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1182\/blood-2016-09-692541","volume":"129","author":"MA Lunning","year":"2017","unstructured":"Lunning MA, Vose JM. Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma. Blood. 2017;129(9):1095\u2013102. https:\/\/doi.org\/10.1182\/blood-2016-09-692541.","journal-title":"Blood"},{"issue":"1","key":"931_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41375-021-01321-2","volume":"36","author":"JC Pritchett","year":"2022","unstructured":"Pritchett JC, Yang ZZ, Kim HJ, Villasboas JC, Tang X, Jalali S, et al. High-dimensional and single-cell transcriptome analysis of the tumor microenvironment in angioimmunoblastic T cell lymphoma (AITL). Leukemia. 2022;36(1):165\u201376. https:\/\/doi.org\/10.1038\/s41375-021-01321-2.","journal-title":"Leukemia"},{"issue":"10","key":"931_CR5","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1038\/s41375-020-0990-y","volume":"34","author":"S Chiba","year":"2020","unstructured":"Chiba S, Sakata-Yanagimoto M. Advances in understanding of angioimmunoblastic T-cell lymphoma. Leukemia. 2020;34(10):2592\u2013606. https:\/\/doi.org\/10.1038\/s41375-020-0990-y.","journal-title":"Leukemia"},{"issue":"4","key":"931_CR6","doi-asserted-by":"publisher","first-page":"466","DOI":"10.2353\/jmoldx.2006.060016","volume":"8","author":"BT Tan","year":"2006","unstructured":"Tan BT, Warnke RA, Arber DA. The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. J Mol Diagn. 2006;8(4):466\u201375; quiz 527. https:\/\/doi.org\/10.2353\/jmoldx.2006.060016.","journal-title":"The J Mol Diagn"},{"issue":"3","key":"931_CR7","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1309\/6UTX-GVC0-12ND-JJEU","volume":"117","author":"A Zettl","year":"2002","unstructured":"Zettl A, Lee SS, R\u00fcdiger T, Starostik P, Marino M, Kirchner T, et al. Epstein-Barr virus\u2013associated B-Cell lymphoproliferative disorders in angioimmunoblastic T-Cell lymphoma and peripheral T-Cell lymphoma, unspecified. Am J Clin Pathol. 2002;117(3):368\u201379. https:\/\/doi.org\/10.1309\/6UTX-GVC0-12ND-JJEU.","journal-title":"Am J Clin Pathol"},{"key":"931_CR8","doi-asserted-by":"publisher","unstructured":"Zhu M, Li N, Fan L, Wu R, Cao L, Ren Y, et al. Single-cell transcriptomic and spatial analysis reveal the immunosuppressive microenvironment in relapsed\/refractory angioimmunoblastic T-cell lymphoma. Blood Cancer J. 2024;14(1):14. 218. https:\/\/doi.org\/10.1038\/s41408-024-01199-0.","DOI":"10.1038\/s41408-024-01199-0"},{"key":"931_CR9","unstructured":"Yan WW, Xu JY, Li LN, Lyu R, Shou LH, Sun Q, et al. Angioimmunoblastic T-cell lymphoma with monoclonal B cell and plasma cell hyperplasia. Zhonghua Xue Ye Xue Za Zhi. 2023;44. 783\u201386."},{"issue":"1","key":"931_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/imr.12791","volume":"291","author":"S Latour","year":"2019","unstructured":"Latour S, Fischer A. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: lessons from genetic diseases. Immunological Rev. 2019;291(1):174\u201389. https:\/\/doi.org\/10.1111\/imr.12791.","journal-title":"Immunological Rev"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00931-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-026-00931-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00931-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:05:40Z","timestamp":1779447940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40364-026-00931-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["931"],"URL":"https:\/\/doi.org\/10.1186\/s40364-026-00931-1","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was granted by the Ethics and Human Research Committees of the Institute of Hematology & Blood Disease Hospital (CAMS & PUMC) and Zhejiang Cancer Hospital (approvals IIT2021030-EC-1 and IRB-2018-105). All procedures involving human participants were conducted in accordance with the ethical standards of the institutional research committees and with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors confirm that they have obtained written consent from each patient to publish the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}